These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32454254)

  • 1. Proteomic analyses reveal divergent ubiquitylation patterns in hepatocellula carcinoma cell lines with different metastasis potential.
    Sun Y; Zheng X; Yuan H; Chen G; Ouyang J; Liu J; Liu X; Xing X; Zhao B
    J Proteomics; 2020 Aug; 225():103834. PubMed ID: 32454254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic analysis of ubiquitinated proteins in 'Xiangshui' lemon [Citrus limon (L.)] pistils after self- and cross-pollination.
    Lin W; Li Y; Luo C; Huang G; Hu G; He X
    J Proteomics; 2022 Jul; 264():104631. PubMed ID: 35644349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
    Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
    J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative proteomics reveals the role of E3 ubiquitin ligase SYVN1 in hepatocellular carcinoma metastasis.
    Ji F; Zhou M; Sun Z; Jiang Z; Zhu H; Xie Z; Ouyang X; Zhang L; Li L
    Cancer Commun (Lond); 2021 Oct; 41(10):1007-1023. PubMed ID: 34196494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering the protein-protein interaction network regulating hepatocellular carcinoma metastasis.
    Qin G; Dang M; Gao H; Wang H; Luo F; Chen R
    Biochim Biophys Acta Proteins Proteom; 2017 Sep; 1865(9):1114-1122. PubMed ID: 28627476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reveal the molecular signatures of hepatocellular carcinoma with different sizes by iTRAQ based quantitative proteomics.
    Wang Y; Liu H; Liang D; Huang Y; Zeng Y; Xing X; Xia J; Lin M; Han X; Liao N; Liu X; Liu J
    J Proteomics; 2017 Jan; 150():230-241. PubMed ID: 27693406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteome Differences between Hepatitis B Virus Genotype-B- and Genotype-C-Induced Hepatocellular Carcinoma Revealed by iTRAQ-Based Quantitative Proteomics.
    Wei D; Zeng Y; Xing X; Liu H; Lin M; Han X; Liu X; Liu J
    J Proteome Res; 2016 Feb; 15(2):487-98. PubMed ID: 26709725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA miR503HG, a prognostic indicator, inhibits tumor metastasis by regulating the HNRNPA2B1/NF-κB pathway in hepatocellular carcinoma.
    Wang H; Liang L; Dong Q; Huan L; He J; Li B; Yang C; Jin H; Wei L; Yu C; Zhao F; Li J; Yao M; Qin W; Qin L; He X
    Theranostics; 2018; 8(10):2814-2829. PubMed ID: 29774077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capn4 overexpression underlies tumor invasion and metastasis after liver transplantation for hepatocellular carcinoma.
    Bai DS; Dai Z; Zhou J; Liu YK; Qiu SJ; Tan CJ; Shi YH; Huang C; Wang Z; He YF; Fan J
    Hepatology; 2009 Feb; 49(2):460-70. PubMed ID: 19053044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence.
    Yi X; Luk JM; Lee NP; Peng J; Leng X; Guan XY; Lau GK; Beretta L; Fan ST
    Mol Cell Proteomics; 2008 Feb; 7(2):315-25. PubMed ID: 17934217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of metastasis candidate proteins among HCC cell lines by comparative proteome and biological function analysis of S100A4 in metastasis in vitro.
    Cui JF; Liu YK; Zhang LJ; Shen HL; Song HY; Dai Z; Yu YL; Zhang Y; Sun RX; Chen J; Tang ZY; Yang PY
    Proteomics; 2006 Nov; 6(22):5953-61. PubMed ID: 17051636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics-based identification of TMED9 is linked to vascular invasion and poor prognoses in patients with hepatocellular carcinoma.
    Yang YC; Chien MH; Lai TC; Tung MC; Jan YH; Chang WM; Jung SM; Chen MH; Yeh CN; Hsiao M
    J Biomed Sci; 2021 Apr; 28(1):29. PubMed ID: 33888099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ANKHD1 is required for SMYD3 to promote tumor metastasis in hepatocellular carcinoma.
    Zhou Z; Jiang H; Tu K; Yu W; Zhang J; Hu Z; Zhang H; Hao D; Huang P; Wang J; Wang A; Xiao Z; He C
    J Exp Clin Cancer Res; 2019 Jan; 38(1):18. PubMed ID: 30646949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic proteomic analysis of human hepotacellular carcinoma cells reveals molecular pathways and networks involved in metastasis.
    Yu Y; Shen H; Yu H; Zhong F; Zhang Y; Zhang C; Zhao J; Li H; Chen J; Liu Y; Yang P
    Mol Biosyst; 2011 Jun; 7(6):1908-16. PubMed ID: 21468425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of CD9 expression reduces the metastatic capacity of human hepatocellular carcinoma cell line MHCC97-H.
    Lin Q; Peng S; Yang Y
    Int J Oncol; 2018 Jul; 53(1):266-274. PubMed ID: 29749468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.
    Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S
    EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNAs are differentially expressed in hepatocellular carcinoma cell lines with differing metastatic potential.
    Fang TT; Sun XJ; Chen J; Zhao Y; Sun RX; Ren N; Liu BB
    Asian Pac J Cancer Prev; 2014; 15(23):10513-24. PubMed ID: 25556502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.
    Xia L; Huang W; Tian D; Zhu H; Qi X; Chen Z; Zhang Y; Hu H; Fan D; Nie Y; Wu K
    Hepatology; 2013 Feb; 57(2):610-24. PubMed ID: 22911555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
    Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
    BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MTBP Promotes the Invasion and Metastasis of Hepatocellular Carcinoma by Enhancing the MDM2-Mediated Degradation of E-Cadherin.
    Lu S; Zhou W; Wei H; He L; Li L
    Dig Dis Sci; 2015 Dec; 60(12):3681-90. PubMed ID: 26280083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.